Page last updated: 2024-09-05

3-cyano-7-ethoxycoumarin and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid

3-cyano-7-ethoxycoumarin has been researched along with (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid in 1 studies

Compound Research Comparison

Studies
(3-cyano-7-ethoxycoumarin)
Trials
(3-cyano-7-ethoxycoumarin)
Recent Studies (post-2010)
(3-cyano-7-ethoxycoumarin)
Studies
((3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid)
Trials
((3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid)
Recent Studies (post-2010) ((3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid)
6031,459368396

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chou, KC; Li, L; Li, YX; Wang, JF; Wei, DQ; Zheng, SY1

Other Studies

1 other study(ies) available for 3-cyano-7-ethoxycoumarin and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid

ArticleYear
3D structure modeling of cytochrome P450 2C19 and its implication for personalized drug design.
    Biochemical and biophysical research communications, 2007, Apr-06, Volume: 355, Issue:2

    Topics: Aryl Hydrocarbon Hydroxylases; Coumarins; Cytochrome P-450 CYP2C19; Drug Design; Fatty Acids, Monounsaturated; Fluvastatin; Fluvoxamine; Indoles; Ligands; Mixed Function Oxygenases; Models, Molecular; Nitriles; Protein Conformation; Structure-Activity Relationship; Ticlopidine

2007